{"id":305552,"date":"2019-11-19T23:00:39","date_gmt":"2019-11-20T07:00:39","guid":{"rendered":"https:\/\/nai500.com\/?p=305552"},"modified":"2019-11-19T23:01:35","modified_gmt":"2019-11-20T07:01:35","slug":"%e4%b8%ad%e5%9c%8b%e4%b8%89%e7%94%9f%e8%a3%bd%e8%97%a5%e9%81%b8%e6%93%87-vtx-0811","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/11\/%e4%b8%ad%e5%9c%8b%e4%b8%89%e7%94%9f%e8%a3%bd%e8%97%a5%e9%81%b8%e6%93%87-vtx-0811\/","title":{"rendered":"\u4e2d\u570b\u4e09\u751f\u88fd\u85e5\u9078\u64c7Verseau\u7684PSGL-1\u9776\u5411\u6297\u9ad4VTX-0811"},"content":{"rendered":"<p><strong>PSGL-1\u662f\u514d\u75ab\u7642\u6cd5\u7684\u65b0\u578b\u9776\u6a19\uff0c\u53ef\u8a98\u5c0e\u5de8\u566c\u7d30\u80de\u91cd\u7de8\u7a0b\u4e26\u6fc0\u6d3b\u5354\u540c\u7684\u6297\u816b\u7624\u708e\u75c7\u53cd\u61c9<\/strong><\/p>\n<p>\u4e09\u751f\u88fd\u85e5\uff08HKEX\uff1a1530\uff09\u548cVerseau Therapeutics, Inc.\uff08\u201c Verseau\u201d\uff09 \u6839\u64da\u96d9\u65b9\u7814\u767c\u548c\u5546\u696d\u5316\u6cbb\u7642\u591a\u7a2e\u764c\u75c7\u7684\u5275\u65b0\u55ae\u514b\u9686\u6297\u9ad4\u7684\u5408\u4f5c\u5354\u8b70\uff0c\u5df2\u9078\u53d6PSGL-1\u9776\u9ede\u7684\u55ae\u514b\u9686\u6297\u9ad4VTX-0811\u4f5c\u70ba\u7b2c\u4e00\u500b\u6388\u6b0a\u7522\u54c1\u3002<\/p>\n<p>\u901a\u904e\u9776\u5411PSGL-1\uff08\u4e00\u7a2e\u7c98\u9644\u5206\u5b50\uff0c\u8a72\u7c98\u9644\u5206\u5b50\u5728\u5927\u591a\u6578\u985e\u578b\u7684\u816b\u7624\u76f8\u95dc\u7684\u5de8\u566c\u7d30\u80de\u4e0a\u9ad8\u8868\u9054\uff09\uff0cVTX-0811\u5c07\u5de8\u566c\u7d30\u80de\u91cd\u7de8\u7a0b\u70ba\u4fc3\u708e\u72c0\u614b\uff0c\u6fc0\u6d3bT\u7d30\u80de\u4e26\u5438\u5f15\u5176\u4ed6\u514d\u75ab\u7d30\u80de\u7522\u751f\u5354\u540c\u800c\u5f37\u5927\u7684\u6297\u816b\u7624\u85e5\u97ff\u61c9\u3002\u8207\u76ee\u524d\u7684\u514d\u75ab\u7642\u6cd5\u76f8\u6bd4\uff0cVerseau\u7684PSGL-1\u6297\u9ad4\u5728PD-1\u53cd\u61c9\u6027\u548c\u975e\u53cd\u61c9\u6027\u816b\u7624\u4e2d\u5747\u8868\u73fe\u51fa\u66f4\u5927\u7684\u708e\u75c7\u53cd\u61c9\u3002 PSGL-1\u662fVerseau\u5de8\u566c\u7d30\u80de\u6aa2\u67e5\u9ede\u8abf\u7bc0\u5668\uff08MCM\uff09\u7cfb\u5217\u4e2d\u7684\u7b2c\u4e00\u500b\u975e\u76f2\u76ee\u76ee\u6a19\u3002 Verseau\u7684MCM\u6839\u64da\u75be\u75c5\u60c5\u6cc1\u5c07\u5de8\u566c\u7d30\u80de\u91cd\u65b0\u7de8\u7a0b\u70ba\u66f4\u5177\u708e\u75c7\u6027\u6216\u81f4\u8010\u53d7\u6027\u3002<\/p>\n<p>Verseau\u9996\u5e2d\u57f7\u884c\u5b98Christine Bunt\u535a\u58eb\u8aaa\uff1a\u201c\u6211\u5011\u5f88\u9ad8\u8208\u5728\u8207\u4e09\u751f\u88fd\u85e5\u7684\u5408\u4f5c\u4e2d\u5be6\u73fe\u4e86\u6211\u5011\u7684\u7b2c\u4e00\u500b\u8a31\u53ef\u91cc\u7a0b\u7891\u3002\u4ed6\u5011\u9078\u64c7VTX-0811\u4f5c\u70ba\u7b2c\u4e00\u500b\u958b\u767c\u8a08\u5283\u7684\u6c7a\u5b9a\u8b49\u5be6\u4e86PSGL-1\u662f\u91cd\u8981\u4e14\u65b0\u7a4e\u7684\u514d\u75ab\u816b\u7624\u9776\u6a19\uff0c\u6709\u671b\u64f4\u5927\u5176\u61c9\u7528\u7bc4\u570d\u3002\u6211\u5011\u7684\u5275\u65b0\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u4f7fVerseau\u80fd\u5920\u63a8\u52d5\u6211\u5011\u884c\u696d\u9818\u5148\u7684\u5de8\u566c\u7d30\u80de\u6aa2\u67e5\u9ede\u8abf\u7bc0\u5291\u7522\u54c1\u7dda\uff0c\u5728\u5404\u7a2e\u764c\u75c7\u7642\u6cd5\u4e2d\u5177\u6709\u4e00\u6d41\u7684\u6f5b\u529b\u3002\u201d<\/p>\n<p>\u4e09\u751f\u88fd\u85e5\u8463\u4e8b\u9577\u517c\u9996\u5e2d\u57f7\u884c\u5b98\u5a41\u7af6\u8868\u793a\uff1a\u201c\u60a3\u8005\u4f86\u6e90\u7684\u539f\u767c\u6027\u816b\u7624\u65e9\u671f\u6578\u64da\u8868\u660e\uff0c\u8207\u76ee\u524d\u7684\u514d\u75ab\u7642\u6cd5\u76f8\u6bd4\uff0c\u5728\u5c0dPD-1\u6709\u97ff\u61c9\u548c\u7121\u97ff\u61c9\u7684\u816b\u7624\u4e2d\uff0cPSGL-1\u6297\u9ad4\u53ef\u4ee5\u7522\u751f\u66f4\u5f37\u7684\u6297\u816b\u7624\u708e\u75c7\u53cd\u61c9\u3002\u901a\u904e\u8207Verseau\u7684\u5408\u4f5c\uff0c\u6211\u5011\u6b65\u5165\u4e86\u514d\u75ab\u816b\u7624\u5b78\u9818\u57df\u6700\u6709\u524d\u666f\u7684\u5275\u65b0\u9818\u57df\u7684\u524d\u6cbf\uff0c\u4e26\u671d\u8457\u70ba\u4e2d\u570b\u7684\u60a3\u8005\u5e36\u4f86\u764c\u75c7\u65b0\u7642\u6cd5\u7684\u76ee\u6a19\u9010\u6b65\u524d\u9032\u3002\u6211\u5011\u671f\u5f85\u5f9e\u6b64\u6b21\u9078\u64c7\u7684\u7b2c\u4e00\u500b\u9805\u76ee\u958b\u59cb\u555f\u52d5\u958b\u767c\uff0c\u540c\u6642\u4e5f\u671f\u5f85\u672a\u4f86Verseau\u7684\u5168\u4eba\u6e90\u8f49\u5316\u91ab\u5b78\u7cfb\u7d71\u7be9\u9078\u51fa\u66f4\u591a\u65b0\u7684\u5de8\u566c\u7d30\u80de\u9776\u9ede\u9805\u76ee\u3002\u201d<\/p>\n<p>\u6839\u64da\u5354\u8b70\u689d\u6b3e\uff0c\u4e09\u751f\u88fd\u85e5\u5c07\u7372\u5f97\u5728\u8a72\u5340\u57df\u7684\u7368\u5bb6\u8a31\u53ef\uff0c\u958b\u767c\u548c\u5546\u696d\u5316\u4e00\u7cfb\u5217\u9069\u7528\u65bc\u6240\u6709\u4eba\u985e\u816b\u7624\u9069\u61c9\u75c7\u7684\u5de8\u566c\u7d30\u80de\u6aa2\u67e5\u9ede\u8abf\u7bc0\u5291\u6297\u9ad4\u3002Verseau\u4fdd\u7559\u5927\u4e2d\u83ef\u5340\u4ee5\u5916\u6240\u6709\u5de8\u566c\u7d30\u80de\u6aa2\u67e5\u9ede\u8abf\u7bc0\u5291\u9805\u76ee\u7684\u5168\u7403\u6b0a\u76ca\u3002Verseau\u5c07\u8ca0\u8cac\u5de8\u566c\u7d30\u80de\u6aa2\u67e5\u9ede\u8abf\u7bc0\u5291\u6297\u9ad4\u7522\u54c1\u7684\u65e9\u671f\u767c\u73fe\u548c\u512a\u5316\u3002\u4e09\u751f\u88fd\u85e5\u5c07\u5728\u8a72\u5340\u57df\u958b\u5c55\u5de8\u566c\u7d30\u80de\u6aa2\u67e5\u9ede\u8abf\u7bc0\u5291\u6297\u9ad4\u81e8\u5e8a\u524d\u548c\u81e8\u5e8a\u958b\u767c\u3001\u7522\u54c1\u751f\u7522\u3001\u65b0\u85e5\u8a3b\u518a\u548c\u5546\u696d\u5316\u7b49\u4e8b\u5b9c\u3002Verseau\u548c\u4e09\u751f\u88fd\u85e5\u5c07\u6709\u8cc7\u683c\u5728\u8a72\u5340\u57df\u548c\u5168\u7403\u7bc4\u570d\u5167\u7372\u5f97\u7522\u54c1\u92b7\u552e\u7684\u7279\u5b9a\u91cc\u7a0b\u7891\u4ed8\u6b3e\u548c\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>3SBio Inc. (&#8220;3SBio&#8221;) (HKEX:1530) and Verseau Therapeutics, Inc. (&#8220;Verseau&#8221;) today announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first licensed program under their partnership agreement focused on the development and commercialization of novel monoclonal antibodies in the field of immuno-oncology for a broad range of cancers.<\/p>\n","protected":false},"author":9,"featured_media":255303,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,459,564],"class_list":["post-305552","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag-459","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/305552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=305552"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/305552\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/255303"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=305552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=305552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=305552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}